Vinge has advised the Danish VC fund People Ventures in conjunction with its investment in Leia Health, which has developed an app designed to map physical and mental health for postpartum women.
Vinge has advised Platzer in conjunction with the acquisition of NCC’s share in Kineum – a 27 storey high destination building in Gårda, Gothenburg. The project, which was commenced in 2018, has been implemented by Platzer and NCC in a joint venture company.
Vinge advises Tele2 AB (publ) in connection with the signing of its first sustainability linked revolving credit facility in an amount of EUR 700 million, which will be used towards general corporate purposes and working capital requirements.
Velvet Cichlid has announced a public offer to the shareholders of Sleep Cycle AB (publ). The offer values the shares of Sleep Cycle at approximately SEK 862 million.
Vinge has advised Acrinova AB (publ) (“Acrinova” or the “Company”) in connection with the Company’s uplisting to Nasdaq Stockholm. The prospectus was published on 9 December 2022 and trading on Nasdaq Stockholm commenced on 16 December 2022.
Vinge has advised Hansa Biopharma in connection with a directed share issue through which the company raises proceeds of SEK 415.9 million before transaction costs.
Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore Pharma receives gross proceeds of SEK 200 million.
Vinge has advised BICO Group AB in connection with a directed share issue to Sartorius AG, adding a total amount of MSEK 487 to BICO. The subscription price of SEK 76 was equivalent to a premium of 2.7 per cent compared with a 3-day VWAP. In connection with the share issue, BICO and Sartorius have entered into an extensive co-operation agreement concerning technical, sales and marketing issues.
Vinge has advised Eleda in connection with its acquisition of the Finnish company Enerim’s Smart Metering business. The business delivers smart metering services, collection and analysis, to customers throughout Finland.
